What’s the point of the WeConnect registry?
Takeda created WeConnect with a simple idea: direct connection with you, the courageous volunteers of clinical trials, to make the whole process smoother and more straightforward.
It's like getting the inside track – quicker updates, straight talk, and no runaround.
This direct approach isn't just about reducing complications and unnecessary steps; it's about making the clinical trial process more efficient for you.
If you're ready to take part, signing up is a breeze.
*Required
So, what's in it for you?
It's about getting the information and connections you want, right when you need it, with fewer hassles.
This is a place where patients like you can find clinical trials that may match your health needs. It’s more than just a list—it’s a way to connect you with clinical trials for new investigational treatments and give you the information you need to discuss further with your healthcare provider and make informed choices about your health. We want to create a clear and friendly space where patients, their families, and friends can find information, support, and help us make Takeda clinical trials better. Joining a clinical trial means you’re helping us study new investigational medicines and hopefully improve health for people in the future. Think of our WeConnect registry as the first step in this important journey.
By participating in Takeda clinical trials, you become part of a larger movement aimed at discovering new treatments and improving outcomes for future generations. Our registry is your starting point on this journey, offering:
- Comprehensive Access: A wide array of information on Takeda-sponsored clinical trials at your fingertips.
- Empowerment Through Information: The knowledge you need to understand your options and make decisions with your healthcare provider that are right for you.
- Community Engagement: A chance to connect with a clinical network of individuals who share your aspirations and challenges, fostering a sense of belonging and support.
As we look toward the future, our mission is to continually expand our registry, ensuring it remains an invaluable resource for patients and a catalyst for medical breakthroughs. We invite you to explore WeConnect, to become part of a community dedicated to making a difference in the world of medicine. Together, we can pave the way for a healthier future.
Keep connecting.
We know you're interested in signing up for Takeda's WeConnect to get direct communication about Takeda clinical trials, but just in case you are looking for other ways to get involved – please review the information below.
Plasma donation.
Plasma-derived therapies are critical, life-saving medicines that many people with rare and complex diseases rely on. Global demand for plasma-derived products, mainly immunoglobulins, has increased dramatically in recent years.
Plasma Donation and BioLife Plasma Services
BioLife Plasma Services is Takeda’s global plasma collection network and an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies that benefit thousands of people every day.
Learn more about plasma donation and how to help people who require life-saving plasma-based therapies by donating your plasma.
Physician looking to connect?
We at U.S. Medical Affairs at Takeda share your passion for science, evidence-based medicine, and commitment to promoting better health and brighter futures for our patients through potentially innovative medicines.
Our goal is to be readily available to support clinicians and researchers in whatever way we can. We believe the best way to improve disease outcomes is through robust and open communication about the science and clinical evidence.
That’s why we love to hear from medical professionals—to hear your questions, to understand what you’re seeing in the clinic, and to discuss research.
You are encouraged to report side effects or quality issues to Takeda at PVSafetyAmericas@takeda.com . If you prefer, you can report to the Health Authority.
Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved.